DexCom
DXCM
DXCM
919 hedge funds and large institutions have $24.3B invested in DexCom in 2025 Q1 according to their latest regulatory filings, with 109 funds opening new positions, 371 increasing their positions, 306 reducing their positions, and 114 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
919
Holders Change
-20
Holders Change %
-2.13%
% of All Funds
12.48%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
109
Increased
371
Reduced
306
Closed
114
Calls
$401M
Puts
$337M
Net Calls
+$64M
Net Calls Change
-$164M
Top Buyers
| 1 |
UBS AM
Chicago,
Illinois
|
+$200M |
| 2 |
Jennison Associates
New York
|
+$197M |
| 3 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$138M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$136M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$131M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$186M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
-$159M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$146M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$82.8M |
| 5 |
MC
MIG Capital
Newport Beach,
California
|
-$66.9M |
